The Structure of High-Performing Project Management Organizations Randolph H. Case OriginalPaper 30 December 1998 Pages: 577 - 607
Effect of Regenerated Roots and Shoots on Nicotine Production in Tobacco Tissue Culture James A. Saunders OriginalPaper 30 December 1998 Pages: 609 - 617
A Survey of Pharmacoeconomics in the Canadian Pharmaceutical Industry Peng J. ChiangT. R. Einarson OriginalPaper 30 December 1998 Pages: 619 - 627
Structuring the Quality Assurance Function Samuel T. BarnettRoger W. Croswell OriginalPaper 30 December 1998 Pages: 629 - 637
The Role of Systematic Reviews in Pharmacovigilance: A Case Study of Granulocyte-Macrophage Colony Stimulating Factor in Aids Susan Dickinson Ross OriginalPaper 30 December 1998 Pages: 639 - 647
Development of an Interactive Computer-Assisted Program to Manage Medication Therapy in Hiv Infected Patients Michelle M. FoisyAlice Tseng OriginalPaper 30 December 1998 Pages: 649 - 656
The Scientific Basis of Drug-Drug Interactions: Mechanism and Preclinical Evaluation Albert P. Li OriginalPaper 30 December 1998 Pages: 657 - 664
Ensuring Good Statistical Practice in Clinical Research: Guidelines for Standard Operating Procedures (An Update) Philip M. North OriginalPaper 30 December 1998 Pages: 665 - 682
A Review of the Performance of Tests used to Establish Whether There is a Drug Effect in Dose-Response Studies Alan Phillips OriginalPaper 30 December 1998 Pages: 683 - 692
Population Pharmacokinetics and Pharmacodynamics: An Underutilized Resource Susan E. TettNicholas H. G. HolfordAndrew J. McLachlan OriginalPaper 30 December 1998 Pages: 693 - 710
Neonatal Mouse Tumorigenicity Bioassay Peter P. FuLinda S. Von TungelnFred F. Kadlubar OriginalPaper 30 December 1998 Pages: 711 - 728
Tacrine Treatment and Nursing Home Placement: Application of the Cox Proportional Hazards Model With Time-Dependent Covariates Fraser SmithStephen GraconLon Schneider OriginalPaper 30 December 1998 Pages: 729 - 735
The Value of Surrogate Endpoints for Evaluation of Therapeutic Efficacy Thomas Robert WeihrauchPierre Demol OriginalPaper 30 December 1998 Pages: 737 - 743
The Challenge of Global Electronic Submission Standards in the Biopharmaceutical Industry Ronald D. Fitzmartin OriginalPaper 30 December 1998 Pages: 745 - 756
Structured Document Generation—A Cornerstone of Document Management Stephen Lander OriginalPaper 30 December 1998 Pages: 757 - 760
Utilization of Drug Information Systems by Medical Representatives in the Japanese Pharmaceutical Industry Manai YamamotoTomoko IizukaSeizaburo Okada OriginalPaper 30 December 1998 Pages: 761 - 767
Comparison and Analysis of the National Drug Code Systems Among Drug Information Databases Jeff Jianfei GuoMark C. DiehlKenneth N. Barker OriginalPaper 30 December 1998 Pages: 769 - 775
Drug Information Sources: Reported Preferences By General Practitioners Cecilia Stålsby LundborgLars-Olof HensjöLars L. Gustafsson OriginalPaper 30 December 1998 Pages: 777 - 785
A Study of Trends in Pharmaceutical Regulatory Approval Times for Nine Major Markets in the 1990s Kate E. ThomasNeil McAuslaneDavid K. Luscombe OriginalPaper 30 December 1998 Pages: 787 - 801
Homeopathic Medicinal Products in Germany and Europe: Legal Requirements for Registration and Marketing Authorization Konstantin Keller OriginalPaper 30 December 1998 Pages: 803 - 811
Project Portfolio Management: A Powerful Strategic Weapon in Pharmaceutical Drug Development Rolf F. TiggemannDavid A. DworaczykHermann Sabel OriginalPaper 30 December 1998 Pages: 813 - 824
Selection Criteria for Phase I Contract Research Organizations by Pharmaceutical Companies Pierre Rosenzweig OriginalPaper 30 December 1998 Pages: 825 - 830
Advances in Pharmaceutical Market Integration in Mercosur and Other Latin American Countries Marcelo J. VernengoKees de JoncheereEnrique Fefer OriginalPaper 30 December 1998 Pages: 831 - 839
The “N” in Pain is Silent: One Company’s Approach to Fda Pre-NDA Approval Inspections Martin D. Hynes IIIRichard M. Justice JR.William J. Chiasson OriginalPaper 30 December 1998 Pages: 841 - 858
